GSK
Gsk Plc-spon Adr.
$43.67
Earnings Summary
Revenue | $7884Mn |
Net Profits | $1173Mn |
Net Profit Margins | 14.88% |
Highlights
Gsk Plc-spon Adr.’s revenue fell -3.23% since last year same period to $7884Mn in the Q2 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 0% jump in its revenue since last 3-months.
Gsk Plc-spon Adr.’s net profit fell -19.88% since last year same period to $1173Mn in the Q2 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 0% jump in its net profits since last 3-months.
Gsk Plc-spon Adr.’s net profit margin fell -17.2% since last year same period to 14.88% in the Q2 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 0% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Gsk Plc-spon Adr. post its latest quarter earnings
EPS Estimate Current Quarter | 1.23 |
EPS Estimate Current Year | 1.23 |
Highlights
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 1.23 - a 24.24% jump from last quarter’s estimates.
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 1.23.
Key Ratios
Key ratios of the Gsk Plc-spon Adr. post its Q2 2024 earnings
Earning Per Share (EPS) | 1.1 |
Dividend Per Share (DPS) | 0.38 |
Highlights
Gsk Plc-spon Adr.’s earning per share (EPS) jumped 13.4% since last year same period to 1.1 in the Q2 2024. This indicates that the Gsk Plc-spon Adr. has generated 13.4% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Gsk Plc-spon Adr. declared 0.38 dividend per share during the earnings announcement for Q2 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-07-31 | 0.99 | 1.1 | 11.11% |
2024-05-01 | 0.91 | 1.09 | 19.78% |
₹0 US Stocks a/c Opening Fee